Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.
Yamamoto Y, Iwata H, Saji S, Takahashi M, Yoshinami T, Ueno T, Toyama T, Yamanaka T, Takano T, Kashiwaba M, Tsugawa K, Hasegawa Y, Tamura K, Tada H, Hara F, Fujisawa T, Niikura N, Taira N, Morita S, Toi M, Ohno S, Masuda N.
Yamamoto Y, et al. Among authors: tada h.
J Clin Oncol. 2025 Jan 24:JCO2401673. doi: 10.1200/JCO-24-01673. Online ahead of print.
J Clin Oncol. 2025.
PMID: 39854662